关注
Mark Taylor
Mark Taylor
Professor
在 edinburghpractice.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Suicide and schizophrenia: a systematic review of rates and risk factors
K Hor, M Taylor
Journal of psychopharmacology 24 (4_suppl), 81-90, 2010
11902010
A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia
J Tiihonen, J Haukka, M Taylor, PM Haddad, MX Patel, P Korhonen
American Journal of Psychiatry 168 (6), 603-609, 2011
7582011
Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial
JR Geddes, GM Goodwin, J Rendell, JM Azorin, A Cipriani, MJ Ostacher, ...
Lancet 375 (9712), 2009
4992009
Mortality in schizophrenia: a measurable clinical endpoint
CJ Bushe, M Taylor, J Haukka
Journal of psychopharmacology 24 (4_suppl), 17-25, 2010
3002010
“First do no harm.” A systematic review of the prevalence and management of antipsychotic adverse effects
SL Young, M Taylor, SM Lawrie
Journal of Psychopharmacology 29 (4), 353-362, 2015
2362015
Hippocampal volume reduction in schizophrenia: effects of genetic risk and pregnancy and birth complications
N Stefanis, S Frangou, J Yakeley, T Sharma, P O’Connell, K Morgan, ...
Biological psychiatry 46 (5), 697-702, 1999
1671999
A new self-rating scale for detecting atypical or second-generation antipsychotic side effects
L Waddell, M Taylor
Journal of Psychopharmacology 22 (3), 238-243, 2008
1602008
First-generation antipsychotic long-acting injections v. oral antipsychotics in schizophrenia: systematic review of randomised controlled trials and observational studies
PM Haddad, M Taylor, OS Niaz
The British Journal of Psychiatry 195 (S52), s20-s28, 2009
1552009
Dopamine D2 receptor occupancy in vivo by the novel atypical antipsychotic olanzapine — a123 IBZM single photon emission tomography (SPET) study
LS Pilowsky, GF Busatto, M Taylor, T Sharma, T Sigmundsson, DC Costa, ...
Psychopharmacology 124, 148-153, 1996
1471996
Attitudes of patients and mental health staff to antipsychotic long-acting injections: systematic review
L Waddell, M Taylor
The British journal of psychiatry 195 (S52), s43-s50, 2009
1432009
Antipsychotic long-acting injections: mind the gap
MX Patel, M Taylor, AS David
The British Journal of Psychiatry 195 (S52), s1-s4, 2009
1172009
Agenesis of the corpus callosum: a United Kingdom series of 56 cases
M Taylor, AS David
Journal of Neurology, Neurosurgery & Psychiatry 64 (1), 131-134, 1998
1161998
How to compare doses of different antipsychotics: a systematic review of methods
MX Patel, IA Arista, M Taylor, TRE Barnes
Schizophrenia research 149 (1-3), 141-148, 2013
1142013
Antipsychotics and abnormal liver function tests: systematic review
KFM Marwick, M Taylor, SW Walker
Clinical neuropharmacology 35 (5), 244-253, 2012
1002012
Hippocampal volume in familial and nonfamilial schizophrenic probands and their unaffected relatives
K Schulze, C McDonald, S Frangou, P Sham, A Grech, T Toulopoulou, ...
Biological psychiatry 53 (7), 562-570, 2003
932003
Brain volumes in adult survivors of very low birth weight: a sibling-controlled study
P Fearon, P O’Connell, S Frangou, P Aquino, C Nosarti, M Allin, M Taylor, ...
Pediatrics 114 (2), 367-371, 2004
882004
NICE CG178 Psychosis and Schizophrenia in Adults: Treatment and Management–an evidence-based guideline?
M Taylor, U Perera
The British Journal of Psychiatry 206 (5), 357-359, 2015
862015
Clozapine: dangerous orphan or neglected friend?
S Farooq, M Taylor
The British Journal of Psychiatry 198 (4), 247-249, 2011
822011
Towards consensus in the long‐term management of relapse prevention in schizophrenia
M Taylor, I Chaudhry, M Cross, E McDonald, P Miller, L Pilowsky, ...
Human Psychopharmacology: Clinical and Experimental 20 (3), 175-181, 2005
802005
Should long-acting (depot) antipsychotics be used in early schizophrenia? A systematic review
M Taylor, KYB Ng
Australian & New Zealand Journal of Psychiatry 47 (7), 624-630, 2013
792013
系统目前无法执行此操作,请稍后再试。
文章 1–20